A549 bronchoalveolar carcinoma cells |
overexpression of human AhRR |
diminished anchorage-dependent and -independent cell growth, reduced angiogenic potential (tube formation) |
73 |
A549 cells |
transient RNAi of AhRR |
enhanced anchorage-dependent and -independent cell growth |
73 |
BP1 mammary epithelial cells |
overexpression of fish AhRR (Fundulus heteroclitus) |
reduced constitutive AhR activity; reduced expression of CYP1B1 |
60 |
MCF7 breast cancer cells |
overexpression of human AhRR |
reduced cell proliferation; increased expression of cyclin D1; reduced expression of E2F and cathepsin D |
86 |
MCF7 cells |
overexpression of human AhRR |
reduced expression of the estrogen-responsive genes pS2, cathepsin D, and complement C3 |
87 |
MCF7 cells |
transient RNAi of AhRR |
no effect on TCDD-induced expression of CYP1A1, CYP1B1, and TCDD- inducible poly (ADP-ribose) polymerase |
125 |
MCF-10AT1 mammary epithelial cells |
overexpression of murine AhRR |
enhanced susceptibility towards UV-induced apoptosis |
87 |
MCF-10A mammary epithelial cells |
stable RNAi targeting AhRR |
induced colony formation in soft agar |
73 |
MCF-10F mammary epithelial cells |
overexpression of fish AhRR (F. heteroclitus) |
reduced cell proliferation |
85 |
MCF-10F cells |
lentiviral overexpression of fish AhRR (F. heteroclitus) |
reduced constitutive AhR activity; reduced expression of CYP1B1 |
60 |
HC11 mammary epithelial cells |
overexpression of human AhRR |
reduced expression of 3-casein |
126 |
HepG2 hepatoma cells |
overexpression of human AhRR |
reduced expression of the estrogen-responsive genes pS2, cathepsin D, and complement C3 |
87 |
Hs578T breast cancer cells |
overexpression of fish AhRR (F. heteroclitus) |
reduced constitutive AhR activity; no effect on cell proliferation |
127 |
Hs578T cells |
overexpression of fish AhRR (F. heteroclitus) |
increased expression of the proto-oncogene c-myc |
128 |